Company Profile
Changzhou Medi-tech Bioscientific Co., Ltd. is a supplier of inhibitors and intermediates used in drug discovery and pre-clinical development. We also have experienced contract labs and offer custom synthesis. Our credo is to provide the products and services with high quality and competitive prices.
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(-)-Blebbistatin Supplier (CAS 856925-71-8) Purity >98% in stock-Meditechbs |
(-)-BLEBBISTATIN;4H-Pyrrolo[2,3-b]quinolin-4-one, 1,2,3,3a-tetrahydro-3a-hydroxy-6-methyl-1-phenyl-, (3aS)-;(+/-)-BLEBBISTATIN;(S)-(-)-BLEBBISTATIN;(-)-Blebbistatin - CAS 856925-71-8 - Calbiochem;(3aS)-3a-hydroxy-6-methyl-1-phenyl-2,3-dihydropyrrolo[2,3-b]quinolin-4-one;CS-978;3a-Hydroxy-6-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one (-)-Blebbistatin |
856925-71-8 | - / 98% | Inquiry |
4SC-202 Supplier (CAS 910462-43-0) Purity >99% in stock-Meditechbs |
4SC-202 (free base);(E)-N-(2-aminophenyl)-3-(1-(4-(1-methyl-1H-pyrazol-4-yl)phenylsulfonyl)-1H-pyrrol-3-yl)acrylamide;(2E)-N-(2-Aminophenyl)-3-[1-[[4-(1-methyl-1H-pyrazol-4-yl)phenyl]sulfonyl]-1H-pyrrol-3-yl]-2-propenamide |
910462-43-0 | - / 98% | Inquiry |
ABT-199 Supplier (CAS 1257044-40-8) Purity >99% in stock-Meditechbs |
Benzamide,4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-;4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide;ABT 199;GDC 0199;Venetoclax;Venclexta;Venclyxto;RG 7601;RG7601;RG-7601 |
1257044-40-8 | - / 99% | Inquiry |
ABT-737 Supplier (CAS 852808-04-9) Purity >98% in stock-Meditechbs |
Benzamide,4-[4-[(4′-chloro[1,1′-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]-;4-[4-[(4′-Chloro[1,1′-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide;ABT 737 |
852808-04-9 | Pharma Grade / 98% | Inquiry |
ABT751 Supplier (CAS 141430-65-1) Purity >98% in stock-Meditechbs |
Benzenesulfonamide,N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxy-;N-[2-[(4-Hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonamide;E 7010;E 7010 (pharmaceutical);N-[2-[(4-Hydroxyphenyl)amino]-3-pyridyl]-4-methoxybenzenesulfonamide;ABT 51;ABT 751;857447-92-8 |
141430-65-1 | - / 98% | Inquiry |
AC55541 Supplier (CAS 916170-19-9) Purity >98% in stock-Meditechbs |
(2E)-2-[1-(3-Bromophenyl)ethylidene]α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineaceticacidhydrazide;AC 55541;(2E)-2-[1-(3-Bromophenyl)ethylidene] α-(benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineacetic acid hydrazideAC55541;AOB2796;alpha-(Benzoylamino)-3,4-dihydro-4-oxo-1-phthalazineacetic acid (2E)-2-[1-(3-bromophenyl)ethylidene]hydrazide |
916170-19-9 | - / 98% | Inquiry |
Afatinib Supplier (CAS 439081-18-2) Purity >98% in stock-Meditechbs |
2-Butenamide,N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;915958-11-1 |
439081-18-2 | - / 98% | Inquiry |
AGI5198 Supplier (CAS 1355326-35-0) Purity >98% in stock-Meditechbs |
N-cyclohexyl-2-(N-(3-fluorophenyl)-2-(2-Methyl-1H-iMidazol-1-yl)acetaMido)-2-(o-tolyl)acetaMide;AGI5198;IDH-C35 /IDHC35;IDH C35;IDH-C35;N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide;1H-Imidazole-1-acetamide, N-[2-(cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-;N-[2-(Cyclohexylamino)-1-(2-methylphenyl)-2-oxoethyl]-N-(3-fluorophenyl)-2-methyl-1H-imidazole-1-acetamide AGI 5198 |
1355326-35-0 | Pharma Grade / 98% | Inquiry |
AP26113 Supplier (CAS 1197958-12-5) Purity >99% in stock-Meditechbs |
2,4-Pyrimidinediamine,5-chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-;5-Chloro-N2-[4-[4-(dimethylamino)-1-piperidinyl]-2-methoxyphenyl]-N4-[2-(dimethylphosphinyl)phenyl]-2,4-pyrimidinediamine |
1197958-12-5 | - / 98% | Inquiry |
ARRY-520 Supplier (CAS 885060-09-3) Purity >98% in stock-Meditechbs |
1,3,4-Thiadiazole-3(2H)-carboxamide,2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-,(2S)-;(2S)-2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide;Filanesib;ARRY 520;(2S)-2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide |
885060-09-3 | - / 98% | Inquiry |
AT7519 Supplier (CAS 844442-38-2) Purity >98% in stock-Meditechbs |
1H-Pyrazole-3-carboxamide,4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl-;4-[(2,6-Dichlorobenzoyl)amino]-N-4-piperidinyl-1H-pyrazole-3-carboxamide;4-(2,6-Dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid N-(piperidin-4-yl)amide;AT 7519;AT 7519M;AT 7517;4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide;1109289-42-0 |
844442-38-2 | Pharma Grade / 98% | Inquiry |
AVL-292 Supplier (CAS 1202757-89-8) Purity >98% in stock-Meditechbs |
AVL-292;LMK-435;N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide;2-Propenamide, N-[3-[[5-fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-;CC-292 (AVL-292);CC-292,LMK-435;N-[3-[[5-Fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide AVL292;CC-292 |
1202757-89-8 | - / 98% | Inquiry |
Axitinib Supplier (CAS 319460-85-0) Purity >98% in stock-Meditechbs |
Benzamide,N-methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]-;N-Methyl-2-[[3-[(1E)-2-(2-pyridinyl)ethenyl]-1H-indazol-6-yl]thio]benzamide;AG 013736;Axitinib;Inlyta;790713-39-2 |
319460-85-0 | - / 98% | Inquiry |
AZD-1080 Supplier (CAS 612487-72-6) Purity >98% in stock-Meditechbs |
AZD 1080;AZD1080;AZD-1080;2-Hydroxy-3-[5-[(morpholin-4-yl)methyl]pyridin-2-yl]-1H-indole-5-carbonitrile;2-Hydroxy-3-[5-[(morpholin-4-yl)methyl]pyridin-2-yl]-1H-indole-5-carbonitrileAZD1080;2-Hydroxy-3-(5-(morpholinomethyl)pyridin-2-yl)-1H-indole-5-carbonitrile |
612487-72-6 | Pharma Grade / 98% | Inquiry |
AZD-3463 Supplier (CAS 1356962-20-3) Purity >98% in stock-Meditechbs |
ALK/IGF1R inhibitor;AZD 3463;AZD3463;AZD-3463;N-[4-(4-Amino-1-piperidinyl)-2-methoxyphenyl]-5-chloro-4-(1H-indol-3-yl)-2-pyrimidinamine;2-Pyrimidinamine, N-[4-(4-amino-1-piperidinyl)-2-methoxyphenyl]-5-chloro-4-(1H-indol-3-yl)-;N-[4-(4-Amino-1-piperidinyl)-2-methoxyphenyl]-5-chloro-4-(1H-indol-3-yl)-2-pyrimidinamine AZD3463;N-(4-(4-Aminopiperidin-1-yl)-2-methoxyphenyl)-5-chloro-4-(1H-indol-3-yl)pyrimidin-2-amine |
1356962-20-3 | Pharma Grade / 98% | Inquiry |
AZD-4547 Supplier (CAS 1035270-39-3) Purity >98% in stock-Meditechbs |
AZD-4547;rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide;AZD4547/AZD-4547;AZD4547, Free Base, >99%;rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamideAZD4547;N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-rel-3,5-dimethylpiperazin-1-yl)benzamide;rel-N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-3,5-dimethylpiperazin-1-yl)benzamide;AZD4547, >=98% |
1035270-39-3 | - / 98% | Inquiry |
AZD1208 Supplier (CAS 1204144-28-4) Purity >98% in stock-Meditechbs |
AZD 1208;AZD1208;AZD-1208;(5Z)-5-[[2-[(3R)-3-aMino-1-piperidinyl][1,1'-biphenyl]-3-yl]Methylene]-2,4-thiazolidinedione;(R,Z)-5-((2-(3-aMinopiperidin-1-yl)-[1,1'-biphenyl]-3-yl)Methylene)thiazolidine-2,4-dione;(5Z)-5-[[2-[(3R)-3-Amino-1-piperidinyl][1,1'-biphenyl]-3-yl]methylene]-2,4-thiazolidinedioneAZD1208;(R,Z)-5-((2-(3-aminopiperidin-1-yl)biphenyl-3-yl)methylene)thiazolidine-2,4-dione;AZD1208 >=95% |
1204144-28-4 | - / 98% | Inquiry |
AZD2461 Supplier (CAS 1174043-16-3) Purity >98% in stock-Meditechbs |
AZD2461;4-[4-Fluoro-3-[(4-methoxypiperidin-1-yl)carbonyl]benzyl]phthalazin-1(2H)-one;1(2H)-Phthalazinone, 4-[[4-fluoro-3-[(4-methoxy-1-piperidinyl)carbonyl]phenyl]methyl]-;AZD 2461, >=98% |
1174043-16-3 | - / 98% | Inquiry |
AZD6482 Supplier (CAS 1173900-33-8) Purity >98% in stock-Meditechbs |
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid;(R)-2-(1-(7-Methyl-2-morpholino-4-oxo-4H-pyrido[1,2-a]pyrimidin-9-yl)ethylamino)benzoic acid;AZD 6482;AZD6482(PI3-kinase β inhibitor);AZD-6482/AZD6482;AZD6482(r);(R)AZD64822-[[(1R)-1-[7-Methyl-2-(4-Morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyriMidin-9-yl]ethyl]aMino]benzoic acid;KIN-193 |
1173900-33-8 | - / 98% | Inquiry |
AZD9291 Supplier (CAS 1421373-65-0) Purity >99% in stock-Meditechbs |
2-Propenamide,N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-;N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide;AZD 9291;Osimertinib;Tagrisso;1610419-47-0 |
1421373-65-0 | - / 98% | Inquiry |
CONTACT INFORMATION
Sign In for Details